Enlightenment of a new era of cancer therapy: prognostication, target selection, and subsequent therapy determined by the dual tumor-immune phenotype
Holbrook Kohrt, MD, PhD; Pamela Kunz, MD
Finished Projects
Epigenetic dysregulation of transposons in pancreatic neuroendocrine tumors
Parijat Senapati, PhD
Epigenetic regulators of intestinal endocrine cells and carcinoid tumors
Qiao Zhou, PhD; Ramesh Shivdasani, MD, PhD
Epigenomic analysis of intestinal neuroendocrine cells and the epigenetic basis of NETs
Ramesh Shivdasani, MD, PhD
Establishment and genome characterization of PNET mouse models
Trevor Pugh, PhD, FACMG
Establishment of novel PDXovo models for neuroendocrine neoplasms
Iacovos Michael, PhD
Evaluation of Ac-225 dotatate for treatment of lung carcinoid tumors
David Morse, PhD
Ex vivo compound prioritization for gastroenteropancreatic NETs
Andrea Califano, PhD
Exploring the role of epigenetic dysregulation in PanNET progression
Sita Kugel, PhD
Functionalized silica nanoparticles: development of a combined PET and TAT theranostic agent for NETs
Tara Mastren, PhD